Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01436032 · ClinicalTrials.gov registry record · Phase 3
Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery
A Phase 3 study, sponsored by Alkermes.
- Terminated
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
NCT01436032: Clinical Trial Phase 3 study, sponsored by Alkermes.
NCT01436032 is a Phase 3 study that was terminated before completion, run by Alkermes. The registered enrollment target is 50 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01436032, a Phase 3 study, was terminated before completion, sponsored by Alkermes.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the analgesic efficacy and safety of N1539 in subjects undergoing abdominal laparoscopic surgery.
Interventions
- DRUG Placebo
- DRUG Ketorolac Tromethamine
- DRUG N1539
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
Why NCT01436032 stopped before completion
NCT01436032 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01436032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01436032 about?
NCT01436032 is a clinical study titled "Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery". The purpose of this study is to determine the analgesic efficacy and safety of N1539 in subjects undergoing abdominal laparoscopic surgery.
What is the current status of trial NCT01436032?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2011-10. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01436032?
The interventions under investigation include: Placebo (DRUG), Ketorolac Tromethamine (DRUG), N1539 (DRUG).
Who is sponsoring clinical trial NCT01436032?
This trial is sponsored by Alkermes, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01436032's enrollment target sits among peer trials
50 1844th of 2000 higher than 141 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia